The latest call
FetchingShoulder Innovations, Inc. reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$20.69-1.9%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Company outlook: revenue of $68M to $70M for Fiscal year 2026 — up 45.8% on a year earlier
Just reported
From Shoulder Innovations, Inc.'s results release of November 5, 2026; its quarterly report has since been filed.
Actual
$16.2M
+38% y/y
-5.7% q/q
Guided
—
No guide given
Actual
-$0.34
Guided
—
No guide given
Actual
-$7.6M
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $16.2M | $11.8M | +37.73% |
| Profit | -$7M | -$8.7M | +19.26% |
| Profit per share | -$0.34 | -$0.64 | +46.88% |
| Free Cash Flow | -$7M | -$11.4M | +38.63% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Shoulder Innovations, Inc. reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Our third quarter results reflect the consistency of our commercial model, as we added new surgeons ahead of plan, grew volume within our existing customer base, and kept our product roadmap moving,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Shoulder Innovations, Inc.’s Item 2.02 8-K filed November 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.